A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Status:
RECRUITING
Trial end date:
2032-10-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).